BridgeBio Pharma, Inc. (BBIO)
71.43
-0.24
(-0.33%)
USD |
NASDAQ |
Dec 10, 12:51
BridgeBio Pharma EPS Diluted (Quarterly): -0.9525 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Pfizer Inc. | 0.6197 |
| Alnylam Pharmaceuticals, Inc. | 1.840 |
| Supernus Pharmaceuticals, Inc. | -0.7978 |
| Ionis Pharmaceuticals, Inc. | -0.805 |
| Regeneron Pharmaceuticals, Inc. | 13.62 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -184.94M |
| Revenue (Quarterly) | 120.70M |
| Total Expenses (Quarterly) | 303.44M |
| Enterprise Value | 15.88B |
| Gross Profit Margin (Quarterly) | 93.98% |
| Profit Margin (Quarterly) | -153.2% |
| Earnings Yield | -5.86% |
| Normalized Earnings Yield | -5.733 |